These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3598225)

  • 1. Rabies preexposure prophylaxis with human diploid cell rabies vaccine: a dose-response study.
    Fishbein DB; Pacer RE; Holmes DF; Ley AB; Yager P; Tong TC
    J Infect Dis; 1987 Jul; 156(1):50-5. PubMed ID: 3598225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination.
    Bernard KW; Mallonee J; Wright JC; Reid FL; Makintubee S; Parker RA; Dwyer DM; Winkler WG
    JAMA; 1987 Feb; 257(8):1059-63. PubMed ID: 3806894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses.
    Bernard KW; Roberts MA; Sumner J; Winkler WG; Mallonee J; Baer GM; Chaney R
    JAMA; 1982 Feb; 247(8):1138-42. PubMed ID: 7057603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries.
    Bernard KW; Fishbein DB; Miller KD; Parker RA; Waterman S; Sumner JW; Reid FL; Johnson BK; Rollins AJ; Oster CN
    Am J Trop Med Hyg; 1985 May; 34(3):633-47. PubMed ID: 4003672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic Response of 2 Versus 3 Doses and Intradermal Versus Intramuscular Administration of a Licensed Rabies Vaccine for Preexposure Prophylaxis.
    Endy TP; Keiser PB; Wang D; Jarman RG; Cibula D; Fang H; Ware L; Abbott M; Thomas SJ; Polhemus ME
    J Infect Dis; 2020 Apr; 221(9):1494-1498. PubMed ID: 31802120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine.
    Arora A; Moeller L; Froeschle J
    J Travel Med; 2004; 11(4):195-9. PubMed ID: 15541220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route.
    Denis M; Knezevic I; Wilde H; Hemachudha T; Briggs D; Knopf L
    Vaccine; 2019 Oct; 37 Suppl 1():A99-A106. PubMed ID: 30551985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety.
    Quiambao BP; Lim JG; Bosch Castells V; Augard C; Petit C; Bravo C; Delore V; Houillon G
    Vaccine; 2022 Aug; 40(36):5347-5355. PubMed ID: 35933278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal immunization with human diploid cell rabies vaccine. Serological and clinical responses of persons with and without prior vaccination with duck embryo vaccine.
    Burridge MJ; Baer GM; Sumner JW; Sussman O
    JAMA; 1982 Oct; 248(13):1611-4. PubMed ID: 7109184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days.
    Soentjens P; Andries P; Aerssens A; Tsoumanis A; Ravinetto R; Heuninckx W; van Loen H; Brochier B; Van Gucht S; Van Damme P; Van Herrewege Y; Bottieau E
    Clin Infect Dis; 2019 Feb; 68(4):607-614. PubMed ID: 29939243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to achieve predicted antibody responses with intradermal and intramuscular human diploid cell rabies vaccine.
    Lemon SM; Miller RN; Pang LW; Prier RE; Bernard KW
    Lancet; 1984 May; 1(8386):1098-100. PubMed ID: 6144829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice.
    Yu P; Yan J; Wu W; Tao X; Lu X; Liu S; Zhu W
    Virol J; 2018 Nov; 15(1):174. PubMed ID: 30424815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine.
    Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB
    J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rate of insufficient antibody titers after single-day immunization with human diploid-cell-strain vaccine against rabies.
    Täuber MG; Putzi R; Fuchs P; Wyler R; Lüthy R
    Klin Wochenschr; 1986 Jun; 64(11):518-21. PubMed ID: 3723999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal use of human diploid cell vaccine for preexposure rabies immunizations.
    Dreesen DW; Sumner JW; Brown J; Kemp DT
    J Am Vet Med Assoc; 1982 Dec; 181(12):1519-23. PubMed ID: 7161170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: an observational study.
    Lau CL; Hohl N
    Travel Med Infect Dis; 2013; 11(6):427-30. PubMed ID: 24135254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.
    Manning SE; Rupprecht CE; Fishbein D; Hanlon CA; Lumlertdacha B; Guerra M; Meltzer MI; Dhankhar P; Vaidya SA; Jenkins SR; Sun B; Hull HF;
    MMWR Recomm Rep; 2008 May; 57(RR-3):1-28. PubMed ID: 18496505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.